暂无分享,去创建一个
Ravishankar K. Iyer | Oluwasanmi Koyejo | Yogatheesan Varatharajah | Brent M. Berry | O. Koyejo | Y. Varatharajah | R. Iyer | Oluwasanmi Koyejo
[1] D. Berry,et al. Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. , 1995, Statistics in medicine.
[2] Christopher J O'Donnell,et al. Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. , 2012, Circulation.
[3] Giancarlo Agnelli,et al. Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials , 2007, Stroke.
[4] Ravishankar K. Iyer,et al. Data-driven longitudinal modeling and prediction of symptom dynamics in major depressive disorder: Integrating factor graphs and learning methods , 2017, 2017 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB).
[5] M. Zelen,et al. Play the Winner Rule and the Controlled Clinical Trial , 1969 .
[6] Balaji Padmanabhan,et al. SCENE: a scalable two-stage personalized news recommendation system , 2011, SIGIR.
[7] H. Robbins. A Stochastic Approximation Method , 1951 .
[8] Wei Chu,et al. A contextual-bandit approach to personalized news article recommendation , 2010, WWW '10.
[9] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[10] J. Cummings,et al. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.
[11] Peter Auer,et al. Using Confidence Bounds for Exploitation-Exploration Trade-offs , 2003, J. Mach. Learn. Res..
[12] Maria Martinez-Lage,et al. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease. , 2008, Archives of neurology.
[13] Daniel V.T. Catenacci,et al. Next‐generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity , 2014, Molecular oncology.
[14] W. R. Thompson. ON THE LIKELIHOOD THAT ONE UNKNOWN PROBABILITY EXCEEDS ANOTHER IN VIEW OF THE EVIDENCE OF TWO SAMPLES , 1933 .
[15] Benjamin Van Roy,et al. A Tutorial on Thompson Sampling , 2017, Found. Trends Mach. Learn..
[16] J. Marshall. Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.
[17] Marco Bonetti,et al. Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP , 2016, Clinical trials.
[18] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[19] Pengfei Guo,et al. A meta-analysis of randomized controlled trials , 2019, Medicine.
[20] Shipra Agrawal,et al. Analysis of Thompson Sampling for the Multi-armed Bandit Problem , 2011, COLT.
[21] J. Broderick,et al. Heart disease and stroke. , 1993, Heart disease and stroke : a journal for primary care physicians.
[22] C. Coffey,et al. Adaptive Clinical Trials , 2008, Drugs in R&D.
[23] J. Bather,et al. Multi‐Armed Bandit Allocation Indices , 1990 .
[24] Jack Bowden,et al. Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challenges. , 2015, Statistical science : a review journal of the Institute of Mathematical Statistics.
[25] Michael L. Littman,et al. Reinforcement learning improves behaviour from evaluative feedback , 2015, Nature.
[26] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[27] C. Stein. A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance , 1945 .
[28] Sofía S Villar,et al. Covariate-Adjusted Response-Adaptive Randomization for Multi-Arm Clinical Trials Using a Modified Forward Looking Gittins Index Rule , 2017, Biometrics.
[29] Draft Guidance. Guidance for Industry Adaptive Design Clinical Trials for Drugs and Biologics DRAFT GUIDANCE , 2010 .
[31] Matthias Schilling,et al. Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success , 2014, Experimental & Translational Stroke Medicine.
[32] D. Berry. Adaptive clinical trials: the promise and the caution. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] R. Simon,et al. Adaptive Signature Design: An Adaptive Clinical Trial Design for Generating and Prospectively Testing A Gene Expression Signature for Sensitive Patients , 2005, Clinical Cancer Research.